Leviton, A <br/><br/>
Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.  [electronic resource] 

 -  Pediatrics  Apr 1997 
 - E2 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1098-4275 
<br/><br/><label>Standard No.: </label>10.1542/peds.99.4.e2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Brain--drug effects<br/>Cerebral Hemorrhage--diagnostic imaging<br/>Cerebral Palsy--diagnostic imaging<br/>Confounding Factors, Epidemiologic<br/>Echoencephalography<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Infant, Newborn<br/>Infant, Premature<br/>Infant, Very Low Birth Weight<br/>Leukomalacia, Periventricular--diagnostic imaging<br/>Logistic Models<br/>Magnesium Sulfate--pharmacology<br/>Odds Ratio<br/>Pre-Eclampsia--drug therapy<br/>Pregnancy<br/>Pregnancy Complications, Cardiovascular--drug therapy<br/>Prospective Studies